Participate in a Study
What We Do
Direct-to-Patient Site
Patient Recruitment
Research-Grade Nursing
Case Studies
Who We Are
About Us
Investigators
News
Resources
Careers
Events
Contact Us
hello world!
Blogs
blog
The FDA Recognizes the Importance of Adopting Decentralized Trial Elements
In its Final Guidance on Decentralized Clinical Trials, the FDA provides recommendations for trial sponsors […]
blog
Evolution or Revolution? How Clinical Trial Recruitment Is Moving from Traditional Patient Referrals to Fully Consented Patient Enrollment
How vital is clinical trial patient recruitment to the overall success of a clinical research […]
blog
You Can Work from Home, You Can See a Doctor from Home…and Now You Can Participate in a Clinical Trial from Home
How At-Home Clinical Trials are Removing Barriers and Increasing Inclusivity in Clinical Research Former U.S. […]
blog
Embracing Virtual in Psychiatry Research
The field of clinical research has undergone a remarkable transformation in recent years, accelerated by […]
blog
Rare Disease Research: The Impact of Decentralized Trials
Authors: Jonathan Cotliar, MD and Suzanne Pendl, MD Collectively, rare diseases are not so rare. […]
blog
How Decentralized Trials Transform Patient Recruitment
Author: Erica Prowisor, Senior Vice President, Patient and Provider Networks, Science 37 In the dynamic […]
blog
Decentralized Clinical Trials: Why They Matter
Author: Darcy Forman, Chief Delivery Officer, Science 37 In the past few years, the clinical […]
blog
The Time for Decentralized Clinical Trials is Now
The FDA Draft Guidance on Decentralized Clinical Trials provides recommendations for clinical trial sponsors to […]
blog
Three Ways the Metasite™ Model Creates Value for Dermatologic Clinical Trials
Author: Robert Stavert, M.D., M.B.A, Medical Director, Dermatology, Science 37 The past decade has brought […]
blog
Treated Like a Human, Not a Statistic
Virtual clinical trial access program provided breast cancer patients with personal, in-home treatment during the […]
blog
A Conversation with Freenome and Jonathan Cotliar, M.D., Chief Medical Officer, Science 37
In a few words, what is Science 37 and what is the benefit of decentralized […]
blog
Top Five Reasons to Include Virtual Sites in Your Infectious Disease Research
Author: Debra Weinstein, MD, Vice President - Internal Medicine Virtual sites can help deliver infectious […]
blog
4 Things to Know about the EMA’s Updated Decentralized Clinical Trial Recommendations
Authors: Jen Davis, Deputy General Counsel & Chief Privacy Officer and Silvia Chia, Senior Director […]
blog
Science 37 Forecast—The Adoption of Hybrid Oncology Trials Will Accelerate in 2023 & Beyond
Author: Dr. Shaalan Beg, Vice President, Oncology Oncology is a therapeutic area of singular importance […]
blog
What Clinical Trial Patient Participants Want
Author: Darcy Forman, Chief Delivery Officer, Science 37 In clinical trials, participant satisfaction is critical […]
blog
Pharma Execs Prefer Hybrid Clinical Trials
Author: Darcy Forman, Chief Delivery Officer Decentralized clinical trial methods are being adopted at a […]
blog
A Long-Time Pharmaceutical Executive’s Experience Participating in a Clinical Trial
With 15 years of experience in pharmaceuticals, Science 37’s Leah Zilla thought she knew what to expect […]
blog
Decentralized Clinical Trials—Where the Industry is Now
Author; Darcy Forman, Chief Delivery Officer The widespread adoption of telemedicine ushered in by the […]
blog
Refining, Rethinking & Decentralizing Clinical Research
Reducing study cycle times and making research more accessible to patients have been among the […]
blog
How Accelerating eCOA Implementation Benefits Decentralized Clinical Trials
Before COVID-19, the clinical trial space was already increasingly implementing remote data collection. Regulatory agencies […]
blog
Is Your Clinical Trial Technology Disconnected?
Author: Elisa Cascade, Chief Product Officer, Science 37 How to improve patient, site, sponsor and […]
blog
Cancer Patients Prefer Decentralized Trials
Author: Dr. Shaalan Beg Decentralized clinical trials have officially become the norm – at least […]
blog
Improving the Patient Journey & Increasing Equitable Access in Oncology Research
by Dr. Shaalan Beg, Vice President of Oncology at Science 37 A 38-year-old mother with stage […]
blog
Building Inclusive Clinical Trials: Strategies to Include the LGBTQIA+ Community
As we consider the strides made in awareness and visibility through Pride Month, we look […]
blog
A New Era of Accessible Clinical Trials
In 2005, International Clinical Trials Day was launched to commemorate the day when James Lind started what […]
blog
A New Era of Accessible Clinical Trials
In 2005, International Clinical Trials Day was launched to commemorate the day when James Lind started what […]
blog
Investing in our Mobile Nursing Network and Elevating our Nurses Voices
International Nurses Day is celebrated every May 12 on the birthday of Florence Nightingale. This year, […]
blog
New Diversity Reporting Imperatives For Clinical Trial Sponsors By Lawmakers & Regulators
The pharmaceutical industry has been put on notice that the diversity of patient populations in […]
blog
A New Clinical Leadership—The Agile Clinical Trial
Industry leaders tout speed, flexibility, and data quality as drivers of success. The pandemic made […]
blog
Enhancing CNS Studies with Agile and Decentralized Clinical Trials
By moving seamlessly between traditional and decentralized components, implementing Agile (hybrid) Clinical Trials will help […]
blog
Breaking Through Mistrust to Better Mental Health in Black Communities
Reflecting upon Science 37’s “Mental Health & Clinical Trials in the Black Community” webinar (presented with George Floyd […]
blog
Powering Rare Disease Research with Agile, Decentralized and Patient-Centric Approaches
The increased adoption of more agile, decentralized, and more patient-centric approaches is a very welcome […]
blog
Reshaping Clinical Trials in 2022
Author: Darcy Forman, Chief Delivery Officer, Science 37 The world is ready – and able […]
blog
Privacy By Design Protects Clinical Trial Participants
Author: Jen Davis, JD, MBA, MA, CIPP/E, CIPP/USDeputy General Counsel and Privacy Officer, Science 37 […]
blog
How Access to the HPV Vaccination is Helping to Eliminate Cervical Cancer
With the arrival of Cervical Health Awareness Month, comes news out of the U.K. that the human […]
blog
Working with Native Americans to Navigate the COVID-19 Crisis
This Native American Heritage Month, we strive to raise awareness on how we can help […]
Privacy & Consent
Privacy Policy
Cookies Notice & Consent
Mobile Privacy Policy
Terms & Conditions
SMS Texting Terms & Conditions
Consumer Health Privacy Notice
Privacy Choices
What We Do
Direct-to-Patient Site
Patient Recruitment
Research-Grade Nursing
Case Studies
Who We Are
About Us
Investigators
News
Resources
Careers
Events
Contact Us
Participate in a Study
© 2025 Science 37 | All Rights Reserved
linkedin